2021
DOI: 10.1111/1471-0528.16892
|View full text |Cite
|
Sign up to set email alerts
|

Serious complications and recurrences after pelvic organ prolapse surgery for 2309 women in the VIGI‐MESH registry

Abstract: Objective To assess the incidence of serious complications and reoperations for recurrence after surgery for pelvic organ prolapse (POP) and compare the three most common types of repair. Design Prospective cohort study using a registry. Setting Nineteen French surgical centres. Population A total of 2309 women participated between 2017 and 2019. Methods A multivariate analysis including an inverse probability of treatment weighting approach was used to obtain three comparable groups. Main outcome measures Ser… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
12
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(13 citation statements)
references
References 26 publications
(58 reference statements)
1
12
0
Order By: Relevance
“…All these complications occurred in the postoperative period and none were reported to have occurred intraoperatively. These results concur with those reported in previous studies that used the VIGI-MESH database [ 11 ]. There were a total of six vaginal mesh exposures reported in relation to both anterior and posterior SSLF.…”
Section: Discussionsupporting
confidence: 93%
See 3 more Smart Citations
“…All these complications occurred in the postoperative period and none were reported to have occurred intraoperatively. These results concur with those reported in previous studies that used the VIGI-MESH database [ 11 ]. There were a total of six vaginal mesh exposures reported in relation to both anterior and posterior SSLF.…”
Section: Discussionsupporting
confidence: 93%
“…The VIGI-MESH registry includes data from 24 French health centers prospectively collected between May 2017 and September 2021. This registry started in 2017 following its approval by the Comité de Protection des Personnes Ouest III (Institutional Review Board) (IDRBC 2017-A000308-45) and was registered on ClinicalTrials.gov (NCT03052985) in February 2017 [ 7 , 11 ]. Twenty-four French Health Centers participated in this registry.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Furthermore, the pathophysiology of mesh-related complications and recurrent prolapse are unclear. Based on the existing literature, it is difficult to ascertain whether adverse outcomes following minimally invasive SCP is related to modifiable factors, such as surgical technique, or related to patient factors, such as connective tissue integrity [ 3 ].…”
Section: Introductionmentioning
confidence: 99%